Repurposing of the CDK inhibitor PHA-767491 as a NRF2...

  • Main
  • 2018 / 1
  • Repurposing of the CDK inhibitor PHA-767491 as a NRF2...
Investigational New Drugs 2018 / 1

Repurposing of the CDK inhibitor PHA-767491 as a NRF2 inhibitor drug candidate for cancer therapy via redox modulation

Liu, Hsiu-Yu, Tuckett, Andrea Z., Fennell, Myles, Garippa, Ralph, Zakrzewski, Johannes L.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Investigational New Drugs
DOI:
10.1007/s10637-017-0557-6
Date:
January, 2018
File:
PDF, 1.37 MB
english, 2018
Conversion to is in progress
Conversion to is failed